<?xml version="1.0" encoding="UTF-8"?>
<fig id="fig2">
 <label>Figure 2</label>
 <caption>
  <p>Vaccine-associated antibody responses.</p>
  <p>Antibody responses for each dose are shown for available specimens from the modified intention-to-treat population. (A) shows the geometric mean endpoint titre (95% CI error bars) and the proportion of participants who developed antibodies against Middle East respiratory syndrome (MERS) coronavirus determined by S1-ELISA. B shows the geometric mean endpoint titre (95% CI error bars) and the proportion of participants who developed neutralising antibodies against MERS coronavirus determined by EMC-2012 MERS-coronavirus infection of Vero cells.</p>
 </caption>
 <graphic xlink:href="gr2_lrg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
